APUS Earnings

Quarterly EPS
$-2.60
Q2 2025
$-1.40
Q3 2025
$-0.03
Q4 2025
$-2.26
Q1 2026
Latest RevenueN/A
Latest Net Income-35059852
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q1 2026-$2.260-35059852
Q4 2025-$0.030-1155292
Q3 2025-$1.400-1781255
Q2 2025-$2.600-2662193
Apimeds Pharmaceuticals US (APUS) — Earnings